Scientists have found a way to identify and interpret ‘signatures’ that reveal the complex genetic causes of some of the deadliest cancers – which often have a survival rate of less than 10%. ̽»¨Ö±²¥results, published today in Nature, could allow them to develop more accurate treatments and significantly improve survival rates.
̽»¨Ö±²¥nine Cambridge researchers were all selected for their exceptional contributions to science.
Nine Cambridge academics have won Advanced Grants awarded by the European Research Council (ERC). This is the greatest number of grants won by a UK institution in the 2021 round of funding.
Patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test that is performed after treatment, according to researchers at the ̽»¨Ö±²¥ of Cambridge.
Cambridge scientists are set to receive a major cash injection from Cancer Research UK.
Every patient with cancer has a story to tell of their journey through diagnosis and treatment. We meet a group of women who are at the centre of pioneering research in Cambridge that’s changing the outcome of ovarian cancer – helping to create treatments that are as unique as their stories.
GE Healthcare, the ̽»¨Ö±²¥ of Cambridge and Cambridge ̽»¨Ö±²¥ Hospitals have agreed to collaborate on developing an application aiming to improve cancer care, with Cambridge providing clinical expertise and data to support GE Healthcare’s development and evaluation of an AI-enhanced application that integrates cancer patient data from multiple sources into a single interface.
Four ̽»¨Ö±²¥ of Cambridge researchers – Professors Shankar Balasubramanian, David Klenerman, Suchitra Sebastian and Jack Thorne – have been recognised by the Breakthrough Prize Foundation for their outstanding scientific achievements.Â
Abnormal cells that develop into oesophageal cancer – cancer that affects the tube connecting the mouth and stomach – start life as cells of the stomach, according to scientists at the ̽»¨Ö±²¥ of Cambridge.
Researchers from the Cancer Research UK Cambridge Institute have developed two tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.
© 2025 ̽»¨Ö±²¥ of Cambridge